SURVIVAL rateBREAST surgeryTREATMENT effectivenessIntroduction: Extreme Oncoplastic Breast Conservation Surgery (EOBCS) is offered in selected patients with multifocal or multicentric breast cancer (MFMC). Recent evidence has suggested that EOBCS may be a valuable resource for patients with MFMC who may...
Several recent trials have demonstrated that neoadjuvant chemotherapy can allow more patients to successfully undergo breast-conserving treatment (BCT), and does not confer a survival disadvantage compared with standard adjuvant chemotherapy. In addition, the pathological response of primary breast tumors to...
PJS is associated with an increased risk of cancer, with an estimated 47% of patients developing a malignancy by age 65. The most common cancers are those of the small intestine, stomach, colon, pancreas, testes, breast, ovary, cervix, and uterus. More than 95% of patients have a ...
and to a minor extent also distant recurrence, and breast cancer death (BCD) [2,3]. However, RT also confers side-effects [4,5,6], underscoring the importance of identifying potential patient-groups that do or do not benefit from RT. A number of factors that ...
BMC Cancer (2021) 21:186 https://doi.org/10.1186/s12885-021-07893-7 RESEARCH ARTICLE Open Access High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability Daniel R. ...
Our group has previously reported that women with inflammatory breast cancer (IBC) continue to have worse outcome compared with those with non-IBC. We undertook this population-based study to see if there have been improvements in survival among women with stage III IBC, over time. Patient and...
Association between dietary total antioxidant capacity and breast cancer: a case–control study in a Middle Eastern country. Public Health Nutr. 2021;24(5):965–72. Article PubMed Google Scholar Vece MM, Agnoli C, Grioni S, Sieri S, Pala V, Pellegrini N, et al. Dietary total ...
Kirova YM, Vilcoq JR, Asselain B, et al.: Radiation- induced sarcomas after radiotherapy for breast carcinoma: a large-scale, single institution review. Cancer 2005, 104:856-863.Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A. Radiation-induced sarcomas after radiotherapy for...
Several recent trials have demonstrated that neoadjuvant chemotherapy can allow more patients to successfully undergo breast-conserving treatment (BCT), and does not confer a survival disadvantage compared with standard adjuvant chemotherapy. In addition, the pathological response of primary breast tumors to...
Breast cancer is the most common cancer amongst Australian women and the second most common cause of cancer-related deaths.1 The life-time risk is considered to be as high as 1 in 91 and, as it is a non preventable disease, early detection is important to increasing survival rates. Woman...